comparemela.com

Page 13 - The Production News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Новые инвестиции — новые рабочие места для людей

Новые инвестиции — новые рабочие места для людей
mk.ru - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mk.ru Daily Mail and Mail on Sunday newspapers.

SII seeks DCGI s permission to manufacture Sputnik V

SII seeks DCGI s permission to manufacture Sputnik V ANI 03 Jun 2021, 19:18 GMT+10 By Shalini BhardwajNew Delhi [India], June 3 (ANI): Indian vaccine manufacturing company Serum Institute of India (SII) has sought permission from the Drug Controller General of India (DCGI) for the production of the Russian vaccine Sputnik V in India. SII has applied for a test license to manufacture the COVID-19 vaccine. Currently, Dr Reddy s Lab is the Russian Direct Investment Fund (RDIF) partner, which markets the Sputnik V vaccine in India. RDIF and Dr Reddy s Laboratories had in a joint statement said , Dr Reddy s Laboratories is the brand custodian of the Sputnik V vaccine in India and has the sole distribution right of the first 250 million doses ( first and second dose components included) of the vaccine in India, SII is currently involved in the production of Astrazenaca s Covishield and Novavax.

China s Sinopharm COVID-19 vaccine to COVAX in production

China s Sinopharm COVID-19 vaccine to COVAX in production Xinhua 01 Jun 2021, 20:44 GMT+10 BEIJING, June 1 (Xinhua) China on Tuesday said the first batch of Chinese vaccines supplied to COVAX officially rolled off the production line, which is another important reflection of China s commitment to making its COVID-19 vaccines global public goods with concrete actions. Foreign Ministry spokesperson Wang Wenbin made the remarks during a daily press briefing after the first batch of the Sinopharm vaccine to COVAX officially rolled off the production line on May 31. China has always supported COVAX and has decided to provide 10 million COVID-19 vaccine doses to the COVAX cause. Relevant companies are doing their best to ensure vaccine supply, Wang noted.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.